Skip to main content

Advertisement

SpringerLink
Log in

Pityriasis Versicolor in Children and Adolescents: an Update

  • Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz and M Pereira, Section Editors)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Pityriasis versicolor (PV) is a superficial mycosis that it can occur at any age, even in newborns. In this review, we will describe epidemiological data, mycological characteristics of yeast, pathogenesis and clinical characteristics of the disease, different diagnostic resources, and the current recommendations for treatment.

Recent Findings

The typical morphology and topography of PV allow us to make a quick diagnosis, but atypical presentations have been described. Diagnostic tools, such as dermoscopy, can also reveal patterns that allow the evaluation of characteristics of scales and pigment in lesions. The discovery of new species and new mechanisms of interaction with the host has broadened the panorama of aetiological possibilities.

Summary

Although PV is a common disorder, extensive research is necessary to better understand the pathophysiology of the disease, immunological characteristics of the pathogen-host relationship and resources needed to precisely diagnose the disease, treat the disease, and avoid its chronic and recurrent course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Heidrich D, Daboit TC, Stopiglia CDO, Magagnin CM, et al. Sixteen years of pityriasis versicolor in metropolitan area of Porto Alegre, Southern Brazil. Rev. Inst. Med. Trop. 2015;57:277–80. https://doi.org/10.1590/S0036-46652015000400001This article presents the study with the highest number of patients.

    Article  CAS  Google Scholar 

  2. Negroni R. Historical aspects of dermatomycoses. Clin Dermatol. 2010;28:125–32. https://doi.org/10.1016/j.clindermatol.2009.12.010.

    Article  PubMed  Google Scholar 

  3. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002;15:21–57. https://doi.org/10.1128/CMR.15.1.21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, et al. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018;56:S10–25. https://doi.org/10.1093/mmy/myx134.

    Article  CAS  PubMed  Google Scholar 

  5. Hellgren L, Vincent J. The incidence of tinea versicolor in central Sweden. J Med Microbiol. 1983;16:501–2. https://doi.org/10.1099/00222615-16-4-501.

    Article  CAS  PubMed  Google Scholar 

  6. Gupta A, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16:19–33.

    Article  CAS  Google Scholar 

  7. Wyre HW, Johson T. Neonatal pityriasis versicolor. Arch Dermatol. 1981;117:752–3.

    Article  Google Scholar 

  8. Congly H. Pityriasis versicolor in a 3-month-old boy. Can Med Assoc J. 1984;130:844–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Oliveira-Santana J, Costa-Campos-Filho P, Andrade-De Azevedo LF. Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA. Brazil. An Bras Dermatol. 2013;88:216–21. https://doi.org/10.1590/S0365-05962013000200005.

    Article  Google Scholar 

  10. Sharma A, Rabha A, Choraria S, Hazarika D, et al. Clinicomycological profile of pityriasis versicolor in Assam. Indian J Pathol Microbiol. 2016;59:159–65. https://doi.org/10.4103/0377-4929.182027.

    Article  PubMed  Google Scholar 

  11. Alvarado Z, Pereira C. Fungal diseases in children and adolescents in a referral centre in Bogota. Colombia. Mycoses. 2018;61:543–8. https://doi.org/10.1111/myc.12774.

    Article  CAS  PubMed  Google Scholar 

  12. Ferie J, Dinkela A, Mbata M, Idindili B, et al. Skin disorders among school children in rural Tanzania and an assessment of therapeutic needs. Trop Doct. 2006;36:219–21. https://doi.org/10.1258/004947506778604823.

    Article  CAS  PubMed  Google Scholar 

  13. Kumar-Jena D, Sengupta S, Chandra-Dwari B, Kumar-Ram M. Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol. 2005;71:259–61. https://doi.org/10.4103/0378-6323.16618.

    Article  Google Scholar 

  14. Silva-Rocha WP, De Azevedo MF, Chaves GM. Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil. J Mycol Med. 2017;27:57–64. https://doi.org/10.1016/j.mycmed.2016.08.009.

    Article  CAS  PubMed  Google Scholar 

  15. Yahya H. Knowledge, perception, and practice of patients about pityriasis versicolor in Kaduna. North Central Nigeria. Int J Dermatol. 2017;56:1169–74. https://doi.org/10.1111/ijd.13654.

    Article  PubMed  Google Scholar 

  16. Aljabre SHM, Alzayir AAA, Abdulghani M, Osman OO. Pigmentary changes of tinea versicolor in dark-skinned patients. Int J Dermatol. 2001;40(4):273–5. https://doi.org/10.1046/j.1365-4362.2001.01201.x.

    Article  CAS  PubMed  Google Scholar 

  17. Rodoplu G, Saracli MA, Gümral R, Yildiran ST. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. J Mycol Med. 2014;24:117–23. https://doi.org/10.1016/j.mycmed.2014.02.001.

    Article  CAS  PubMed  Google Scholar 

  18. Xie Z, Ran Y, Zhang H, Zhang M, et al. An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu. China. Sci. World J. 2014. https://doi.org/10.1155/2014/182596.

    Google Scholar 

  19. Ibekwe PU, Ogunbiyi AO, Besch R, Ruzicka T, et al. The spectrum of Malassezia species isolated from students with pityriasis vesicolor in Nigeria. Mycoses. 2015;58:203–8. https://doi.org/10.1111/myc.12298.

    Article  CAS  PubMed  Google Scholar 

  20. Moallaei H, Namazi MJ, Bouchara JP, Pourhammed S. Malassezia species in students from universities of Sabzevar. Northeastern Iran. J Mycol Med. 2018;28:70–5. https://doi.org/10.1016/j.mycmed.2017.12.004.

    Article  CAS  PubMed  Google Scholar 

  21. Elshabrawy WO, Saudy N, Sallam M. Molecular and phenotypic identification and speciation of Malassezia yeasts isolated from Egyptian patients with pityriasis versicolor. J Clin Diagn Res. 2017;11:DC12–7. https://doi.org/10.7860/JCDR/2017/27747.10416.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Diongue K, Kébé O, Faye MD, Samb D, et al. MALDI-TOF MS identification of Malassezia species isolated from patients with pityriasis versicolor at the seafarers’ medical service in Dakar. Senegal. J Mycol Med. 2018;28:590–3. https://doi.org/10.1016/j.mycmed.2018.09.007.

    Article  CAS  PubMed  Google Scholar 

  23. Honnavar P, Ghosh AK, Paul S, Shankarnarayan SA, et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn Microbiol Infect Dis. 2018;92:118–23. https://doi.org/10.1016/j.diagmicrobio.2018.05.015.

    Article  CAS  PubMed  Google Scholar 

  24. Cam VT, Van TN, Hau KT, Huu DL, et al. Distribution of Malassezia species from scales of patient with pityriasis versicolor by culture in Vietnam. Open Access Maced J Med Sci. 2019;7:184–6. https://doi.org/10.3889/oamjms.2019.091.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Awad AK, Al-Ezzy AIA, Jameel GH. Phenotypic identification and molecular characterization of Malassezia Spp. isolated from pityriasis versicolor patients with special emphasis to risk factors in Diyala Province, Iraq. Open Access Maced J Med Sci. 2019;7. https://doi.org/10.3889/oamjms.2019.128.

    Article  Google Scholar 

  26. Ramadán S, Sortino M, Bulacio L, Marozzi ML, et al. Prevalence of Malassezia species in patients with pityriasis versicolor in Rosario, Argentina. Rev Iberoam Micol. 2012;29:14–9. https://doi.org/10.1016/j.riam.2011.03.001.

    Article  PubMed  Google Scholar 

  27. Pedrosa AF, Lisboa C, Gonҫalves-Rodrigues A. Malassezia infections: a medical conundrum. J Am Acad Dermatol. 2014;71:170–6. https://doi.org/10.1016/j.jaad.2013.12.022.

    Article  PubMed  Google Scholar 

  28. Lorch JM, Palmer JM, Vanderwolf KJ, Schmidt KZ, et al. Malassezia vespertilionis sp. nov.: a new cold-tolerant species of yeast isolated from bats. Persoonia. 2018;41:56–70. https://doi.org/10.3767/persoonia.2018.41.04.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Dawson TL. Previews Malassezia : The forbidden kingdom opens. Cell Host Microbe. 2019;25:345–7. https://doi.org/10.1016/j.chom.2019.02.010.

    Article  CAS  PubMed  Google Scholar 

  30. Karakas M, Turaç-Bíçer A, Ilkit M, Durdu M, et al. Epidemiology of pityriasis versicolor in Adana. Turkey. J Dermatol. 2009;36:377–82. https://doi.org/10.1111/j.1346-8138.2009.00663.x.

    Article  PubMed  Google Scholar 

  31. Romero-Sandoval K, Alves-Costa A, Teixeira-Sousa MG, Furucho CR, et al. Recurrent and disseminated pityriasis versicolor: a novel clinical form consequent to Malassezia-host interaction? Med Hypotheses. 2017;109:139–44. https://doi.org/10.1016/j.mehy.2017.10.013.

    Article  PubMed  Google Scholar 

  32. Romano C, Mancianti F, Nardoni S, Ariti G, et al. Identification of Malassezia species isolated from patients with extensive forms of pityriasis versicolor in Siena. Italy. Rev Iberoam Micol. 2013;30:231–4. https://doi.org/10.1016/j.riam.2013.02.001.

    Article  PubMed  Google Scholar 

  33. Brandi N, Starace M, Alessandrini A, Piraccini BM. Tinea Versicolor of the neck as side effect of topical steroids for alopecia areata. J Dermatolog Treat. 2019;22:1–3. https://doi.org/10.1080/09546634.2019.1573308.

    Article  CAS  Google Scholar 

  34. Crespo-Erchiga V, Gómez-Moyano E, Crespo M. La pitiriasis versicolor y las levaduras del género Malassezia. Actas Dermosifiliogr. 2008;99:764–71. https://doi.org/10.1016/S0001-7310(08)74956-1.

    Article  CAS  PubMed  Google Scholar 

  35. Cafarchia C, Gasser RB, Figueredo LA, Stefania M, et al. Advances in the identification of Malassezia. Mol Cell Probes. 2011;25(1):1–7. https://doi.org/10.1016/j.mcp.2010.12.003.

    Article  CAS  PubMed  Google Scholar 

  36. Honnavar P, Prasad GS, Ghosh A, Dogra S, et al. Malassezia arunalokei sp. nov., a novel yeast species isolated from seborrheic dermatitis patients and healthy individuals from India. J Clin Microbiol. 2016;54(7):1826–34. https://doi.org/10.1128/JCM.00683-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hirai A, Kano R, Makimura K, Duarte ER. Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int J Syst Evol Microbiol. 2004;54:623–7. https://doi.org/10.1099/ijs.0.02776-0.

    Article  CAS  PubMed  Google Scholar 

  38. Sugita T, Takashima M, Kodama M, Tsuboi R, et al. Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol. 2003;41:4695–9. https://doi.org/10.1128/JCM.41.10.4695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sugita T, Takashima M, Shinoda T, Suto H, et al. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J Clin Microbiol. 2002;40:1363–7. https://doi.org/10.1128/JCM.40.4.1363.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Petrokilidou C, Pavlou E, Gaitanis G, Bassukas I, et al. The lipid profile of three Malassezia species assessed by Raman spectroscopy and discriminant analysis. Mol Cell Prob. 2019;46:101416. https://doi.org/10.1016/j.mcp.2019.06.006.

    Article  CAS  Google Scholar 

  41. Renati S, Cukras A, Bigby M. Pityriasis versicolor. BMJ. 2015;350:h1394. https://doi.org/10.1136/bmj.h1394.

    Article  PubMed  Google Scholar 

  42. Balestri R, Rech G, Piraccini BM, Antonucci A, et al. Pityriasis versicolor during anti TNF-a monoclonal antibody therapy: therapeutic considerations. Mycoses. 2012;55:444–6. https://doi.org/10.1111/j.1439-0507.2012.02170.x.

    Article  CAS  PubMed  Google Scholar 

  43. He S, Du W, Yang S, Zhou S, et al. The genetic epidemiology of tinea versicolor in China. Mycoses. 2017;51:55–62. https://doi.org/10.1111/j.1439-0507.2007.01437.x.

    Article  Google Scholar 

  44. Tülin Gülec A, Demirbilek M, Seckin D, Can F, et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol. 2003;49:187–92. https://doi.org/10.1067/S0190-9622(03)00861-2.

    Article  PubMed  Google Scholar 

  45. Angiolella L, Leone C, Rojas F, Mussin J, et al. Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur. Med Mycol. 2018;56:110–6. https://doi.org/10.1093/mmy/myx014.

    Article  CAS  PubMed  Google Scholar 

  46. • Grice EA, TLJ D. Host – microbe interactions: Malassezia and human skin. Curr. Opin. Microbiol. 2017;40:81–7. https://doi.org/10.1016/j.mib.2017.10.024An update of the immune response mechanisms in the presence of Malassezia.

    Article  CAS  PubMed  Google Scholar 

  47. Sparber F, Leibundgut-landmann S. Host responses to Malassezia spp. in the mammalian skin. Front Immunol. 2017;22. https://doi.org/10.3389/fimmu.2017.01614.

  48. Lee WJ, Kim JY, Song CH, Jung HD, et al. Disruption of barrier function in dermatophytosis and pityriasis versicolor. J Dermatol. 2011;38:1049–53. https://doi.org/10.1111/j.1346-8138.2011.01320.x.

    Article  PubMed  Google Scholar 

  49. Tellechea Ó, Cravo M, Brinca A, Robalo-Cordeiro M. Pityriasis versicolor atrophicans. Eur J Dermatol. 2012;22:287–8. https://doi.org/10.1684/ejd.2012.1659.

    Article  PubMed  Google Scholar 

  50. Allegue F, Fachal C, Gonzáles-Vilas D, Zulaica A. Atrophying pityriasis versicolor. Actas Dermosifiliogr. 2018;109:455–7. https://doi.org/10.1016/j.ad.2017.08.013.

    Article  CAS  PubMed  Google Scholar 

  51. Marinello E, Piaserico S, Alaibac M. Atrophic pityriasis versicolor occurring in a patient with Sjögren’s syndrome. BMJ Case Rep. 2017. https://doi.org/10.1136/bcr-2016-218108.

  52. Levy JMS, Magro C. Atrophying pityriasis versicolor as an idiosyncratic T cell-mediated response to Malassezia: a case series. J Am Acad Dermatol. 2017;76:730–5. https://doi.org/10.1016/j.jaad.2016.08.062.

    Article  PubMed  Google Scholar 

  53. • Crowson AN, Magro CM. Atrophying tinea versicolor: a clinical and histological study of 12 patients. Int J Dermatol. 2003;42(12):928–32. https://doi.org/10.1111/j.1365-4632.2003.02110.xSeries with the highest number of atrophic PV cases reported so far.

    Article  CAS  PubMed  Google Scholar 

  54. Galadari I, Komy ME, Mousa A, Hashimoto K, et al. Tinea versicolor: histologic and ultraestructural investigation of pigmentary changes. Int J Dermatol. 1992;31(4):253–6. https://doi.org/10.1111/j.1365-4362.1992.tb03565.x.

    Article  CAS  PubMed  Google Scholar 

  55. Thoma W, Krämer H, Maysert P. Pityriasis versicolor alba. J Eur Acad Dermatol Venerol. 2005;19:147–52. https://doi.org/10.1111/j.1468-3083.2004.01085.x.

    Article  CAS  Google Scholar 

  56. Hattori M, Ogawa H, Takamori K, Gritiyaranson P, et al. De- (hypo) pigmentation mechanisms of the affected area of pityriasis versicolor. J. Dermatol. 1984;2:63–6.

    Article  Google Scholar 

  57. Aghaei-Gharehbolagh S, Kordbacheh P, Jamal-Hashemi S, Daie Ghazvini R, et al. MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor. Mycoses. 2018;61:938–44. https://doi.org/10.1111/myc.12840.

    Article  CAS  PubMed  Google Scholar 

  58. Khaddar RK, Cherif F, Hadid RB, Mokni M, et al. Penile shaft involvement in pityriasis versicolor. Acta Dermatoven APA. 2008;17:86–9.

    Google Scholar 

  59. Martínez E, Porras C, Arenas R. Pitiriasis versicolor: estudio de 194 casos con insistencia en la discromía. Dermatol Rev Mex. 2012;56:388–91.

    Google Scholar 

  60. Bonifaz A. Capítulo 8: pitiriasis versicolor. En:. In: Bonifaz A, editor. Micología médica básica. 5ª ed. México: Mc Graw Hill Education; 2015. p. 159–79.

  61. Ramírez-Godínez JB, Carreño-Gayosso EA, Soto-Ortiz JA, Tarango-Martínez VM, et al. Pitiriasis versicolor: una actualización. Med Cutan Iber Lat Am. 2018;46:166–75.

    Google Scholar 

  62. •• Mendez A, Bonifaz A. Formas clínicas excepcionales de pitiriasis versicolor. Dermatol Rev Mex. 2019;63:347–51 A review of the atypical forms of presentation of the PV.

    Google Scholar 

  63. Goldstein BG, Goldstein AO. Tinea versicolor (Pityriasis versicolor). In: Dellavalle RP, Levy ML, Rosen T, editors. UpToDate; 2018. Retrieved aug 1, 2019, from https://www-uptodate-com/contents/tinea-versicolor-pityriasis-versicolor?search=pitiriasis%20versicolor&source=search_result&selectedTitle=1~51&usage_type=default&display_rank=1.

  64. De Graciansky P, Mery F. Atrophie sur pityrisais versicolor aprés corticotherápie local prolongé. Bull Soc Fr Dermatol Syphiligr. 1971;78:295.

    Google Scholar 

  65. Hinojosa-Arias E, Sotelo-García L, Bonifaz A. Pitiriasis versicolor variedad atrófica: a propósito de un caso. Derma Cosmética y Quirúrgica. 2014;12:295–6.

    Google Scholar 

  66. Zawar V, Chuh A. Pityriasis versicolor imbricata – overlapping parallel scales in a novel variant of pityriasis versicolor. J Eur Acad Dermatol Venerol. 2008;22:1143–5. https://doi.org/10.1111/j.1468-3083.2007.02560.x.

    Article  CAS  Google Scholar 

  67. Arenas R. Capítulo 96: Pitiriasis versicolor. En:. In: Arenas R, editor. Dermatología. Atlas, diagnóstico y tratamiento. 5th ed. México: Mc Graw Hill; 2013. p. 472–7.

    Google Scholar 

  68. • Mathur M, Acharya P, Karki A, Nisha K, et al. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 2019;12:303–9. 10.2147@CCID.S195166 A description of dermatoscopic patterns in PV lesions.

  69. Gupta AK, Foley KA. Antifungal treatment for pityriasis versicolor. J Fungi. 2015;1:13–29. https://doi.org/10.3390/jof1010013.

    Article  Google Scholar 

  70. Gupta AK, Lyons DC. Pityriasis versicolor: an update on pharmacological treatment options. Expert Opin Pharmacother. 2014;15:1707–13. https://doi.org/10.1517/14656566.2014.931373.

    Article  CAS  PubMed  Google Scholar 

  71. • Gupta AK, Kogan N, Batra R. Pityriasis versicolor: a review of pharmacological treatment. Expert Opin Pharmacother. 2005;6:165–78. https://doi.org/10.1517/14656566.6.2.165A review of the topical and systemic treatments available for PV.

    Article  CAS  PubMed  Google Scholar 

  72. Hull CA, Johnson SM. A double blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pitiriasis (tinea) versicolor. Cutis. 2004;73:425–9.

    PubMed  Google Scholar 

  73. Prestia AE. Topical benzoyl peroxide for the treatment of tinea versicolor. J Am Acad Dermatol. 1983;9:277–8. https://doi.org/10.1016/s0190-9622(83)80152-2.

    Article  CAS  PubMed  Google Scholar 

  74. Clayton R, Du Vivier A, Savage M. Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. Arch Dermatol. 1977;113:849–50. https://doi.org/10.1001/archderm.1977.01640060145029.

    Article  CAS  PubMed  Google Scholar 

  75. Shi TW, Zhang JA, Tang YB, Yu XH, et al. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. 2015;26:143–6. https://doi.org/10.3109/09546634.2014.921661.

    Article  Google Scholar 

  76. Sepaskhah M, Sadat MS, Pakshir K, Bagheri Z. Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: a single blind, randomised clinical trial. Mycoses. 2017;60:338–42. https://doi.org/10.1111/myc.12598.

    Article  CAS  PubMed  Google Scholar 

  77. Amichai B. Treatment of pityriasis versicolor with a shampoo containing 1% bifonazole (Agispor shampoo) in children. Clin Exp Dermatol. 2000;25:660. https://doi.org/10.1046/j.1365-2230.2000.00730-6.x.

    Article  CAS  PubMed  Google Scholar 

  78. Katsambas A, Rigopoulos D, Antoniou C, Zachari A, et al. Econazole 1 % shampoo versus selenium in the treatment of tinea versicolor: a single-blind randomized clinical study. Int J Dermatol. 1996;35:667–8. https://doi.org/10.1111/j.1365-4362.1996.tb03700.x.

    Article  CAS  PubMed  Google Scholar 

  79. Sarkar S, Sengupta D, Basak S, Damji SA, et al. Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: a prospective, open, randomized controlled trial. Indian Dermatol Online J. 2016;7:335–6. https://doi.org/10.4103/2229-5178.185471.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Haroon TS, Tareen MI. An open study of tioconazole 1% dermal cream in patients with pityriasis versicolor. J Pak Med Assoc. 1984;34:361–2.

    CAS  PubMed  Google Scholar 

  81. Cam VT, Van TN, Hau KT, Huu DL, et al. Efficacy of azole antifungal in treatment of pityriasis versicolor. Open Access Maced J Med Sci. 2019;7:272–4. https://doi.org/10.3889/oamjms.2019.092.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Faergemann J, Todd G, Pather S, Vawda ZF, et al. A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. J Am Acad Dermatol. 2009;61:971–6. https://doi.org/10.1016/j.jaad.2008.08.033.

    Article  CAS  PubMed  Google Scholar 

  83. Hald M, Arendrup MC, Svejgaard EL, Lindskov R, et al. Evidence-based Danish guidelines for the treatment of Malassezia - related skin diseases. Acta Derm Venereol. 2015;95(2015):12–9. https://doi.org/10.2340/00015555-1825.

    Article  CAS  PubMed  Google Scholar 

  84. De Souza Framil MV, Szeszs MW, Melhem MC, Zaitz C. New aspects in the clinical course of pityriasis versicolor. An Bras Dermatol. 2011;86:1135–40. https://doi.org/10.1590/s0365-05962011000600011.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Hospital Infantil de México Federico Gómez, Dr. Márquez 162, Col. Doctores, Del. Cuauhtémoc, CP, 06720, Ciudad de México, México

    Karen Adilene Camargo-Sánchez, Mirna Toledo-Bahena, Carlos Mena-Cedillos & Adriana Valencia-Herrera

  2. Hospital Star Médica Infantil Privado, Ciudad de México, México

    Erika Ramirez-Cortes

  3. Division of Dermatology, Hospital General Dr. Manuel Gea González, Ciudad de México, México

    Sonia Toussaint-Caire

  4. Department of Biomedical Research, Hospital Infantil de México Federico Gómez, Ciudad de México, México

    Marcela Salazar-García

  5. Department of Dermatology and Mycology, Hospital General de México Dr. Eduardo Liceaga, Ciudad de, México, México

    Alexandro Bonifaz

Authors
  1. Karen Adilene Camargo-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mirna Toledo-Bahena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos Mena-Cedillos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erika Ramirez-Cortes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sonia Toussaint-Caire
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adriana Valencia-Herrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marcela Salazar-García
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alexandro Bonifaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adriana Valencia-Herrera.

Ethics declarations

Conflict of Interest

Karen Adilene Camargo-Sánchez, Mirna Toledo-Bahena, Carlos Mena-Cedillos, Erika Ramirez-Cortes, Sonia Toussaint-Caire, Adriana Valencia-Herrera, Marcela Salazar-García, and Alexandro Bonifaz declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Fungal Infections of Skin and Subcutaneous Tissue

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camargo-Sánchez, K.A., Toledo-Bahena, M., Mena-Cedillos, C. et al. Pityriasis Versicolor in Children and Adolescents: an Update. Curr Fungal Infect Rep 13, 157–168 (2019). https://doi.org/10.1007/s12281-019-00360-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-019-00360-8

Keywords

Search

Navigation